Masimo Corp (MASI) Stock Price, Quote & News

Company Profile

Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemog...

Industry: Medical Devices

Sector: Healthcare

Phone: 949 297 7000

Fax: 949 297 7001

Website: www.masimo.com

Address:

52 Discovery, Irvine, United States

SuperGreenToday Jan. 29 at 10:05 PM

$MASI

0 · Reply

ZacksResearch Jan. 29 at 5:59 PM

Why $OWLT beats $MASI in the med-tech race 🚀 🌟 $OWLT surged 71.5% in 6 months, driven by accelerating growth and improving profitability. Its FDA-cleared device and expanding subscription base strengthen its position in pediatric health. 📉 Meanwhile, $MASI's shares fell 11.7%, facing moderate growth and tariff challenges despite strong margins and cash flows. Discover why Owlet could be the growth story of the year 👉 https://www.zacks.com/stock/news/2825271/owlet-vs-masimo-which-medical-monitoring-stock-is-the-better-buy?cid=sm-stocktwits-2-2825271-body-31030&ADID=SYND_STOCKTWITS_TWEET_2_2825271_BODY_31030

0 · Reply

ZacksResearch Jan. 29 at 4:59 PM

$OWLT vs. $MASI — which medical monitoring stock actually has the edge right now? The setup comes down to AI-driven gains and shifting margins, putting Owlet and Masimo head-to-head on upside potential as fundamentals evolve. 📊⚖️ See which stock offers the stronger risk/reward 👉 https://www.zacks.com/stock/news/2825271/owlet-vs-masimo-which-medical-monitoring-stock-is-the-better-buy?cid=sm-stocktwits-2-2825271-teaser-31009&ADID=SYND_STOCKTWITS_TWEET_2_2825271_TEASER_31009

0 · Reply

OfficialStocktwitsUser Jan. 29 at 3:12 PM

$MASI RSI: 50.92, MACD: 0.6854 Vol: 4.89, MA20: 137.65, MA50: 138.80 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Estimize Jan. 19 at 2:01 PM

Wall St is expecting 1.48 EPS for $MASI Q4 [Reporting 03/03 AMC] http://www.estimize.com/intro/masi?chart=historical&metric_name=eps&utm_co

0 · Reply

ZacksResearch Jan. 15 at 4:04 PM

$MASI shares dipped despite strong preliminary Q4 results. Why? 🤔 📊 Estimated Q4 revenues of $411M up 12% on a reported basis, exceeding the Zacks Consensus Estimate of $407.3M 💰 Adjusted EPS expected to exceed $1.54, beating the Zacks Consensus Estimate of $1.40 📉 Stock down 10.9% since Sept. 28, against the industry’s 10.3% rise Is the market missing something? Full analysis here 👉 https://www.zacks.com/stock/news/2818209/masimo-stock-declines-despite-solid-preliminary-q4-revenues?cid=sm-stocktwits-2-2818209-body-29095&ADID=SYND_STOCKTWITS_TWEET_2_2818209_BODY_29095

0 · Reply

ZacksResearch Jan. 15 at 3:04 PM

$MASI sold off — even after solid preliminary Q4 numbers. That’s got my attention. ⚠️👀 The company posted strong fourth-quarter and full-year 2025 preliminary results, with revenue and EPS above estimates, driven by continued momentum in its core healthcare business. Why the disconnect between results and the stock move? Full story here 👉 https://www.zacks.com/stock/news/2818209/masimo-stock-declines-despite-solid-preliminary-q4-revenues?cid=sm-stocktwits-2-2818209-teaser-29059&ADID=SYND_STOCKTWITS_TWEET_2_2818209_TEASER_29059

0 · Reply

11thestate Jan. 15 at 2:06 PM

Imagine buying $MASI at its peak, only to watch it crash like this — and then finding out there’s a way to get some money back. To all $MASI investors out there, we’ve got some important news for you: https://11th.com/cases/masimo-investor-lawsuit

0 · Reply

11thestate Jan. 6 at 2:57 PM

$MASI is now accepting claims for a 33.75M settlement it is paying to investors over claims that it misled investors about its ability to sustain growth after a major acquisition. If you bought $MASI between May 4, 2022 and August 8, 2023, you still can file for payment here: https://11th.com/cases/masimo-investor-lawsuit

0 · Reply

ZacksResearch Jan. 5 at 6:21 PM

Why hold $MASI right now — even with the risks on the table? 🩺 Strong Q3 2025 results, recent FDA clearance, and new partnerships are fueling growth hopes, even as dependence on SET and reimbursement risks remain key overhangs. Get the full bull vs. risk breakdown here 👉 https://www.zacks.com/stock/news/2811973/heres-why-you-should-retain-masimo-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2811973-teaser-27416&ADID=SYND_STOCKTWITS_TWEET_2_2811973_TEASER_27416

0 · Reply

Clairity Appoints Founder Dr. Connie Lehman as Chief Executive Officer; Joe Kiani Named Chairman of the Board

Jan 14, 2026, 7:56 PM EST - 19 days ago

Masimo Corporation (MASI) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 9:00 AM EST - 22 days ago

Masimo Announces Select Preliminary 2025 Financial Results

Jan 7, 2026, 9:00 AM EST - 27 days ago

Masimo to Present in the J.P. Morgan 2026 Healthcare Conference

Jan 2, 2026, 7:22 AM EST - 4 weeks ago

Apple's Rival Masimo Tumbles In Quality Despite $634 Million Patent Win Over iPhone-Maker

AAPL

Dec 11, 2025, 10:37 AM EST - 7 weeks ago

Eight stock picks to play one of the healthiest corners of the market

ALNY ASND INSM NTRA PODD UNH WGS

Dec 5, 2025, 3:20 PM EST - 2 months ago

HALPER SADEH LLC ENCOURAGES MASIMO CORPORATION SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS

Dec 4, 2025, 12:09 PM EST - 2 months ago

Masimo Pitches 2028 Plan With 30% Operating Margins

Dec 4, 2025, 1:13 AM EST - 2 months ago

Masimo Corporation (MASI) Analyst/Investor Day Transcript

Dec 3, 2025, 4:10 PM EST - 2 months ago

Masimo Hosts 2025 Investor Day and Details Strategic Roadmap for Durable Growth

Nov 18, 2025, 9:00 AM EST - 2 months ago

Knobbe Martens Guides Masimo to $634M Win Against Apple in Patent Infringement Case

Nov 17, 2025, 11:35 AM EST - 2 months ago

DRC Congratulates Knobbe Martens on its $634 Million Win for Masimo

Nov 15, 2025, 4:07 PM EST - 2 months ago

Jury says Apple owes Masimo $634M for patent infringement

AAPL

Nov 14, 2025, 11:16 PM EST - 2 months ago

US jury says Apple must pay Masimo $634 million in smartwatch patent case

AAPL

Nov 14, 2025, 8:55 PM EST - 2 months ago

Masimo Issues Statement on California Jury Verdict Finding Patent Infringement by Apple and Awarding Masimo $634 Million in Damages

Nov 4, 2025, 7:36 PM EST - 3 months ago

Masimo Corporation (MASI) Q3 2025 Earnings Call Transcript

Nov 4, 2025, 4:05 PM EST - 3 months ago

Masimo Reports Third Quarter 2025 Results

Oct 23, 2025, 1:00 PM EDT - 3 months ago

Halper Sadeh LLC Encourages Masimo Corporation Shareholders to Contact the Firm to Discuss Their Rights

Oct 21, 2025, 9:00 AM EDT - 3 months ago

Masimo to Report Third Quarter 2025 Financial Results after Market Close on Tuesday, November 4

Oct 9, 2025, 9:00 AM EDT - 4 months ago

Masimo to Host Investor Day on December 3, 2025

Oct 7, 2025, 8:00 AM EDT - 4 months ago

In Feasibility Study for Large, Prospective, Real-World Trial, Masimo SET® Performed Accurately on Critically Ill Adult ICU Patients of All Skin Tones

Sep 23, 2025, 9:00 AM EDT - 4 months ago

Masimo Completes Sale of Consumer Audio Business to HARMAN International

Sep 23, 2025, 9:00 AM EDT - 4 months ago

HARMAN Completes Sound United Acquisition to Expand Premium Audio Leadership

Sep 17, 2025, 8:00 AM EDT - 4 months ago

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs

Sep 11, 2025, 8:00 AM EDT - 5 months ago

Masimo Announces Expansion of Strategic Partnership with Philips

PHG

Sep 4, 2025, 4:29 PM EDT - 5 months ago

Masimo Corporation (MASI) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Aug 28, 2025, 9:00 AM EDT - 5 months ago

Masimo to Present in the Wells Fargo Healthcare Conference

Aug 20, 2025, 6:52 PM EDT - 5 months ago

Masimo sues US Customs over approval of Apple Watch imports

AAPL

Aug 19, 2025, 8:00 AM EDT - 6 months ago

Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters

Aug 7, 2025, 9:45 PM EDT - 6 months ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX BSX EW EXAS GH ISRG LLY

Aug 5, 2025, 11:03 PM EDT - 6 months ago

Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript

Aug 5, 2025, 4:05 PM EDT - 6 months ago

Masimo Reports Second Quarter 2025 Results

Jul 22, 2025, 9:00 AM EDT - 7 months ago

Masimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5

Jul 8, 2025, 8:00 AM EDT - 7 months ago

Masimo Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation

Jun 10, 2025, 8:00 AM EDT - 8 months ago

New Study Finds Masimo SedLine® Brain Function Monitoring Offers Significant Advantages During Pediatric Anesthesia

May 27, 2025, 9:00 AM EDT - 9 months ago

Masimo to Present in the Jefferies Global Healthcare Conference

May 7, 2025, 9:00 AM EDT - 9 months ago

Masimo to Present in the BofA Securities 2025 Health Care Conference

May 6, 2025, 10:15 PM EDT - 9 months ago

Masimo Corporation (MASI) Q1 2025 Earnings Call Transcript

May 6, 2025, 5:06 PM EDT - 9 months ago

Samsung Electronics says unit Harman acquires Masimo's audio business for $350 mln

May 6, 2025, 4:10 PM EDT - 9 months ago

Masimo Reports First Quarter 2025 Results

May 6, 2025, 4:10 PM EDT - 9 months ago

Masimo to Sell Consumer Audio Business to HARMAN International

May 6, 2025, 4:00 PM EDT - 9 months ago

Masimo to Sell Audio Business to Harman After Investor Outrage

Apr 29, 2025, 11:45 AM EDT - 10 months ago

Baron Health Care Fund Q1 2025 Top Net Purchases And Sales

ACLX ISRG MCK NTRA PEN TMO UNH

Apr 24, 2025, 9:00 AM EDT - 10 months ago

Masimo to Report First Quarter 2025 Financial Results after Market Close on Tuesday, May 6

Apr 2, 2025, 9:00 AM EDT - 10 months ago

Masimo to Present in the 24th Annual Needham Virtual Healthcare Conference

Feb 28, 2025, 9:00 AM EST - 1 year ago

Masimo to Present in the 46th Annual Raymond James Institutional Investor Conference

Feb 25, 2025, 6:02 PM EST - 1 year ago

Masimo Corporation (MASI) Q4 2024 Earnings Call Transcript

Feb 25, 2025, 4:05 PM EST - 1 year ago

Masimo Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Updated Full-Year 2025 Guidance

SuperGreenToday Jan. 29 at 10:05 PM

$MASI

0 · Reply

ZacksResearch Jan. 29 at 5:59 PM

0 · Reply

ZacksResearch Jan. 29 at 4:59 PM

0 · Reply

OfficialStocktwitsUser Jan. 29 at 3:12 PM

0 · Reply

Estimize Jan. 19 at 2:01 PM

Wall St is expecting 1.48 EPS for $MASI Q4 [Reporting 03/03 AMC] http://www.estimize.com/intro/masi?chart=historical&metric_name=eps&utm_co

0 · Reply

ZacksResearch Jan. 15 at 4:04 PM

0 · Reply

ZacksResearch Jan. 15 at 3:04 PM

0 · Reply

11thestate Jan. 15 at 2:06 PM

0 · Reply

11thestate Jan. 6 at 2:57 PM

0 · Reply

ZacksResearch Jan. 5 at 6:21 PM

0 · Reply

ZacksResearch Jan. 5 at 5:21 PM

$MASI down 21.6% in 6 months — is growth on the horizon? 📉 Despite recent setbacks, Masimo's innovative tech and strategic partnerships aim to drive future growth. With a Zacks Rank #3, it has beaten earnings estimates in the trailing four quarters, averaging a 12.39% surprise. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2811973/heres-why-you-should-retain-masimo-stock-in-your-portfolio-now?cid=sm-stocktwits-2-2811973-body-27389&ADID=SYND_STOCKTWITS_TWEET_2_2811973_BODY_27389

0 · Reply

Estimize Jan. 5 at 2:00 PM

Wall St is expecting 1.46 EPS for $MASI Q4 [Reporting 03/03 AMC] http://www.estimize.com/intro/masi?chart=historical&metric_name=eps&utm_co

0 · Reply

OfficialStocktwitsUser Jan. 2 at 8:57 PM

$MASI RSI: 21.53, MACD: -3.5640 Vol: 4.27, MA20: 135.86, MA50: 141.50 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Californiamaster Jan. 2 at 5:29 PM

$MASI another new 52 weeks low on January 1

0 · Reply

Californiamaster Dec. 31 at 4:11 PM

$MASI 52 weeks low

0 · Reply

ZacksResearch Dec. 30 at 12:44 PM

Why $DXCM, $RMD, and $MASI could benefit from financial incentives in 2026! 🚀 💰 Higher HSA contribution limits mean more pre-tax savings for devices like CGMs and PAPs. 🔼 Rising Medicare premiums encourage the use of tech for cost-effective chronic disease management. Discover how these stocks are positioned to benefit 👉 https://www.zacks.com/stock/news/2810011/3-stocks-likely-to-gain-from-rising-hsa-contribution-medicare-premium?cid=sm-stocktwits-2-2810011-body-26697&ADID=SYND_STOCKTWITS_TWEET_2_2810011_BODY_26697

0 · Reply

ZacksResearch Dec. 30 at 11:44 AM

💰 Policy tailwinds hitting healthcare — here’s the quiet beneficiary trade. Rising HSA contribution limits and higher Medicare premiums in 2026 could boost demand for chronic care devices, putting $DXCM, $RMD, and $MASI in a favorable spot as patients and providers spend more on long-term care needs. See how these policy shifts could play out 👉 https://www.zacks.com/stock/news/2810011/3-stocks-likely-to-gain-from-rising-hsa-contribution-medicare-premium?cid=sm-stocktwits-2-2810011-teaser-26695&ADID=SYND_STOCKTWITS_TWEET_2_2810011_TEASER_26695

0 · Reply

topstockalerts Dec. 26 at 6:33 PM

Apple shares moved modestly higher after investors reacted to two positive surprises involving China and a U.S. court decision. New data showed that China’s imports of foreign-branded smartphones, including the iPhone, surged 128% year over year in November, pointing to stronger-than-expected demand in one of Apple’s most important markets despite ongoing trade tensions and tariffs. At the same time, a U.S. district court judge denied Masimo’s request to block Apple Watch imports, giving Apple a temporary legal victory in a long-running patent dispute over blood-oxygen sensor technology. While the company still faces legal uncertainty, including a recent jury verdict awarding Masimo substantial damages, the ruling reduced near-term risk. Even with these tailwinds, Apple shares are up about 9% in 2025, trailing the stronger performance of other megacap technology stocks. $AAPL $MASI

0 · Reply

AStrokeOfLuck Dec. 26 at 4:15 PM

$AAPL $MASI

0 · Reply

WallStreetBuyDip Dec. 25 at 8:33 PM

Comparing trending tickers $MASI vs $CORT: MASI dipped slightly by 0.44% to $133.28 with a trading volume of 257.2K shares, which is below its average volume of 663.4K. On the other hand, CORT climbed 1.95% reaching $83.59, on a volume of 313.9K shares, also below its usual trading activity of 1.2M shares. While both stocks are trading below their average volumes today, CORT is showing better price performance with a notable uptick compared to MASI's minor drop.

0 · Reply

WallStreetBuyDip Dec. 25 at 8:06 PM

Comparing trending tickers $MOD vs $MASI: MOD is slightly down today at $137.59, a minor drop of 0.04%, with trading volume at 271.7K, which is below its average of 1.1M shares. MASI also saw a decrease, falling 0.44% to $133.28, with a volume of 257.2K, again below its usual 663.4K shares. Both stocks are trading less actively than usual, but MASI's price has taken a slightly sharper hit in comparison to its average trading volume.

0 · Reply

OfficialStocktwitsUser Dec. 25 at 6:41 PM

$MASI RSI: 31.67, MACD: -2.7228 Vol: 3.45, MA20: 138.80, MA50: 143.22 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Market Cap	7.38B
Revenue (ttm)	2.09B
Net Income (ttm)	-304.90M
EPS (ttm)	N/A
PE Ratio	23.45
Forward PE	23.62
Profit Margin	-14.56%
Debt to Equity Ratio	0.69

Volume	451,700
Avg Vol	760,292
Day's Range	N/A - N/A
Shares Out	53.71M
Stochastic %K	30%
Beta	1.26
Analysts	Strong Sell
Price Target	$183.75